Nicolas Wolikow and Simon Istolainen – The Visionaries Behind Cure51
Discuss Innovation, Challenges, and Their Mission to Transform Oncology Nicolas Wolikow and Simon Istolainen of Cure51 discuss their innovative approach to cancer treatment, emphasising data integration, international collaboration, and overcoming challenges in healthcare innovation. In the rapidly evolving landscape of digital health and precision medicine, two visionary leaders, Nicolas Wolikow and Simon Istolainen, have emerged…